The forecast for respiratory system disease mortality in the US suggests a consistent upward trend from 279.58 thousand deaths in 2024 to 281.06 thousand deaths by 2028. Year-on-year growth is modest, with values showing gradual increases, indicating stability but persistent mortality rates. This represents a small compounded annual growth rate (CAGR) over the forecast period, suggesting continuity rather than abrupt change. In 2023, the mortality figure was 279.2 thousand deaths, marking a minimal increase into 2024.
Future trends to watch include the potential impact of emerging healthcare technologies and therapies, policy changes affecting healthcare quality, and demographic shifts such as an aging population, all of which could significantly alter mortality patterns.
